GGrantIndex
Sort

23,748 grants matching melanoma

Community Outreach and Engagement

$141,556
Chau Trinh-Shevrin · New York University School Of Medicine · P30 · FY2021 · CA

Community Outreach and Engagement

$141,556
Chau Trinh-Shevrin · New York University School Of Medicine · P30 · FY2023 · CA

Community Outreach and Engagement

$141,556
Chau Trinh-Shevrin · New York University School Of Medicine · P30 · FY2022 · CA

CYTOKINES AS CANCER IMMUNOTHERAPEUTICS

$141,520
University Of South Florida · R29 · FY2000 · CA

MOLECULAR AND GENETIC EPIDEMIOLOGY OF GLIOMAS

$141,510
University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA

Project 1: Nanoshells Enabled Tumor Ablation and Immunotherapy

$141,507
Andrew Clyde Kummel · University Of California, San Diego · U54 · FY2016 · CA

Correlative Studies for Phase II Trial of IL12 and IFNa

$141,478
Ohio State University · R21 · FY2001 · CA

Immune targeting of melanoma-associated antigens in glioma

$141,462
Robert M Prins · University Of California Los Angeles · K01 · FY2007 · CA

Combination Therapy that Targets Glutamate Signaling in Melanoma

$141,295
James S Goydos · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2013 · CA

b-catenin in vaccine-induced anti-tumor CD8 T cell immunity

$141,086
Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA

NANOCARRIER BASED INTRALYMPHATIC IMAGING AND THERAPY FOR MELANOMA

$141,012
Mark Steven Cohen · University Of Kansas Lawrence · P20 · FY2009 · RR

Community Ourtreach and Education Core

$140,970
James A Swenberg · Univ Of North Carolina Chapel Hill · P30 · FY2011 · ES

aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy

$140,940
Tonya J. Webb · University Of Maryland Baltimore · K01 · FY2010 · CA

ANIMAL FACILITY

$140,929
Joseph T Newsome · University Of Pittsburgh At Pittsburgh · P30 · FY2012 · CA

Project 2: Role of codon and isoform differences in Ras tumorigenesis

$140,770
Sharon L Campbell · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA

Biostatistics Core

$140,733
Yan Lin · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA

Universal MUC1 Targeted Immunotherapy

$140,720
Rimas J Orentas · Lentigen Corporation · R43 · FY2009 · CA

Obesity Affects Immunity to Kidney Cancer

$140,656
Lyse A Norian · University Of Alabama At Birmingham · R01 · FY2015 · CA

Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression

$140,655
Timothy Louis Frankel · University Of Michigan At Ann Arbor · K08 · FY2019 · CA

Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression

$140,655
Timothy Louis Frankel · University Of Michigan At Ann Arbor · K08 · FY2018 · CA

Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression

$140,655
Timothy Louis Frankel · University Of Michigan At Ann Arbor · K08 · FY2020 · CA

Epigenetic Chromatin Changes as Melanoma Markers

$140,610
Yale University · R21 · FY2005 · CA

Project 1: Nanoshells Enabled Tumor Ablation and Immunotherapy

$140,523
Natalie Allen Gude · San Diego State University · U54 · FY2015 · CA

Role of GPR56 in glomerular endothelial cell injury in early diabetic kidney disease

$140,475
Jia Fu · Icahn School Of Medicine At Mount Sinai · K01 · FY2021 · DK

Biological Models, Molecular Pathology and Biostatistics

$140,448
Guillermo J. Tearney · Massachusetts General Hospital · P01 · FY2011 · CA